Clinical Trials Logo

Sensation Disorders clinical trials

View clinical trials related to Sensation Disorders.

Filter by:

NCT ID: NCT04226651 Completed - Dental Anxiety Clinical Trials

The Effectiveness of Audiovisual Distraction Behavior Guidance Technique in Children With Dental Anxiety

Start date: March 11, 2019
Phase: N/A
Study type: Interventional

This randomized, two‐armed, placebo-controlled, cross-over, controlled trial aimed to evaluate the effect of virtual reality exposure therapy (VRET) on dental anxiety, pain, and behaviour among children undergoing dental treatment under local anaesthesia. The null hypotheses were as follows: VRET has no effect on reducing dental anxiety and dental pain scores of participants; and there is no difference between subjective and objective measure scores of dental anxiety and pain when VRET and attention palcebo-controlled (APC) groups are used to reduce anxiety in children undergoing dental treatment with local anaesthesia.

NCT ID: NCT04158960 Completed - Clinical trials for Autism Spectrum Disorder

Motor Skill Proficiency After Equine-assisted Activities and Brain-building Tasks

Start date: February 1, 2015
Phase: N/A
Study type: Interventional

There is no current research to support the efficacy of a combination of equine-assisted activities (EAA) and brain building activities to influence motor skill competencies in youth with neurodevelopmental disorders (ND). The primary objective of this study was to quantify changes in motor skill proficiency before and after 8 weeks of EAA and brain-building activities in youth with ND. A secondary objective was to quantify changes in motor skill proficiency before and after 1 year of EAA and brain-building activities in youth with ND.

NCT ID: NCT03925571 Completed - Clinical trials for Dental Pain and Sensation Disorders

Musicotherapy in Reducing Peroperative Anxiety and Post-surgical Pain in Dental Care

MUSANX
Start date: May 3, 2019
Phase: N/A
Study type: Interventional

The main purpose of MUSANX study is to highlight analgesic effectiveness of musicotherapy in post-surgical periodontal and implant; and to measure its per-operative anxiolytic effectiveness

NCT ID: NCT03914664 Recruiting - Tourette Syndrome Clinical Trials

Neural Correlates of Sensory Phenomena in Tourette Syndrome

Start date: July 20, 2021
Phase:
Study type: Observational

The most pervasive sensory manifestation of TS is sensory over-responsivity (SOR). SOR is defined as excessive behavioral response to commonplace environmental stimuli. SOR is an integral but poorly understood facet of the TS phenotype, one intertwined with core elements of the disorder and worse QOL. This proposal seeks to clarify the mechanistic bases of SOR in TS. Adults with with TS will be recruited 1) to complete a standardized clinical symptom assessment battery and 2) to undergo electroencephalogram (EEG), autonomic, and audio-visual monitoring during tactile and auditory stimuli paradigms, as well as at rest.

NCT ID: NCT03913143 Active, not recruiting - Eye Diseases Clinical Trials

A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)

ILLUMINATE
Start date: April 4, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this double-masked, randomized, controlled, multiple-dose study is to evaluate the efficacy, safety, tolerability and systemic exposure of sepofarsen (QR-110) administered via intravitreal injection in subjects with Leber's Congenital Amaurosis (LCA) due to the CEP290 p.Cys998X mutation after 24 months of treatment

NCT ID: NCT03913130 Terminated - Eye Diseases Clinical Trials

Extension Study to Study PQ-110-001 (NCT03140969)

INSIGHT
Start date: May 13, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Subjects completing participation in study PQ-110-001 (EudraCT 2017-000813-22 / NCT03140969) will be given the opportunity to enroll into the extension study for continued dosing if available data support current and/or future benefits for the subject. Study PQ-110-002 will provide long-term safety, tolerability, pharmacokinetic (PK), and efficacy data of QR-110.

NCT ID: NCT03805334 Completed - Sleep Clinical Trials

The Effectiveness of Bilateral Alternating Tactile Stimulation for Improving Sleep in Children

Start date: February 12, 2019
Phase: N/A
Study type: Interventional

The investigators hypothesize that wearing bilateral therapeutic vibrating devices before bed will result in positive changes in outcome measures related to sleep (e.g., sleep efficiency) in children who are sensitive to stimuli in their environment (aka sensory over responsiveness or SOR).

NCT ID: NCT03619642 Completed - Stroke Clinical Trials

Reliability, Validity and Clinical Utility of a Robotic Assessment for Proprioception

Start date: December 15, 2017
Phase: N/A
Study type: Interventional

The aim of this case-controlled observational cross-sectional study is to investigate the test-retest reliability, validity and clinical utility of a rapid robotic assessment of finger proprioception using a passive gauge position matching tasks in MS and stroke subjects. Session 1 Informed consent Descriptive measures Session 2 Clinical testing Robotic assessment (3x) Session 3 Clinical testing Robotic assessment (3x)

NCT ID: NCT03538756 Completed - Balance; Distorted Clinical Trials

walk2Wellness: Long-term Effects of Walkasins® Wearable Sensory Prosthesis

Start date: October 22, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the long-term effects of Walkasins® use on clinical and subject-reported outcomes of balance and gait function, quality of life, physical activity/participation, pain, and medication use in persons with peripheral neuropathy who experience balance problems.

NCT ID: NCT03395275 Withdrawn - Chronic Pain Clinical Trials

Intrathecal Morphine Microdose Method Sensory Changes

Start date: October 8, 2018
Phase: N/A
Study type: Interventional

Following the retrospective study on the effectiveness of the microdose method of intrathecal morphine therapy, the investigators are interested in measuring the sensory changes at 4 time points during the microdose method. The microdose method involves weaning the patient off oral opioids and maintaining an opioid-free period prior to initiating a very low opioid dose in intrathecal therapy. The microdose method is a standard of care. The study involves measuring sensory changes to hot, cold, and pressure. Data collection will be performed at regularly scheduled clinic visits, examining range of doses, pain scores,dose escalations, quantifiable psychosocial factors ( not captured in previous retrospective study), and changes in sensory thresholds.